Screening and Profiling Services
Evaluate lead compounds with our biochemical and cell-based screening services to identify specific inhibitors or activators. Save time by letting us screen your small molecules or biologics of interest against our unique assay panels or determine IC50 values. With our portfolio of >600 assays available as a service, we’re here to help advance your drug discovery program.
Our biochemical-based inhibitor screening services provide excellent tools to quickly identify potential therapeutics, predict potency, and narrow down a large pool of candidates to a much smaller one.
To gain insight on cellular functional interventions, we also offer cell-based screening services. The cell-based data offers a more comprehensive view of the biological context and the resulting cellular responses, allowing for more informed decisions to be made about which compounds to advance to development.
We are Uniquely Positioned for Your Discovery
- Extensive Immunotherapy panels, including many unique immunotherapy targets
- First commercially available and largest histone demethylase panel
- Over 20 unique histone methyltransferases
- Extensive SARS-CoV-2 assays, including 3CL Protease, RdRp, Papain-like Protease, and Spike:ACE2 binding assays
- Complete PARP isozyme panel and unique PARP-trapping assays
- Largest phosphodiesterase isozyme panel
- First complete suite of HDAC and SIRT enzymes
- Extensive bromodomain and HSP90 panels
- Over 80 reporter cell lines for cell-based agonist or inhibitor screening and profiling, including many unique receptor/reporter combinations
Accelerating a Path to Discovery
We make the process simple to get you moving on the path of discovery quicker. It starts with your library, whether generated from AI modeling or based on an existing compound library. Select from our extensive portfolio of target-specific service assays, get a quote, and then ship your compounds. We can run single point or multi-point screens or obtain IC50/EC50 dose-response curves as defined in the quote and return results in 2 to 3 weeks depending on the service provided. Upon completion of service, you can choose to run additional screens, expand your compound profiling, or explore our off-the-shelf products to keep your research moving forward.
Our Deliverables to You
Detailed Results
Extensive report with raw and analyzed data, graphs, and detailed protocols. Typically includes positive controls for inhibition.
Fast Turnaround
Receive results within weeks after our receipt of your compounds.
Quality & Consistency
Proteins and enzymes synthesized and QC’d in-house to ensure the highest level of inter- and intra-assay consistency.
Extensive Selection
Choose from over 700 in-house developed assays, including many novel assay kits.
Platform Options
Choose the format that works best for your experiment or perform orthogonal testing on multiple platforms to verify your results.
Expertise
Dedicated, expert screening team
Custom Product Development
Can’t find the product you are looking for? Our experts could build it for you. Learn more.
│Biochemical Screening
- Acetyltransferase
- Apoptosis
- Bromodomain
- Coronavirus
- Deacetylases/Sirtuins
- Demethylase
- HSP90
- Immunotherapy
- Kinase
- KRAS
- Metabolic Enzymes
- Methyl-Lysine Reader
- Methyltransferase
- PARP/PARPTrap™
- PCSK9
- Phosphodiesterase
- Protease
- Protein Tyrosine Phosphatase
- Ubiquitination